Kasparas Petkevicius is a biochemist with expertise in phospholipid metabolism. He studied Biochemistry at the University of Bath (BSc, 2013) and completed a PhD at the University of Cambridge in 2018, focusing on macrophage phospholipid metabolism in obesity. He then joined AstraZeneca in Sweden, first as a postdoctoral fellow and later as an Associate Principal Scientist, working on phospholipid-related targets in metabolic disease. In 2023, he became a junior group leader at the MRC Mitochondrial Biology Unit at the University of Cambridge. His lab investigates how bis(monoacylglycero)phosphate is made in cells and how this pathway is disrupted in Batten disease.